Paper393992
The biochemistry and in vitro activity of soluble factors of activated lymphocytes.
Sorg C. Mol Cell Biochem, 1979. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Download JSON
Cite this record
ConductScience Library. The biochemistry and in vitro activity of soluble factors of activated lymphocytes. Papers, record 393992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/393992
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukocyte Migration-Inhibitory Factors | Major topic |
| Lymphocyte Activation | Major topic |
| Lymphocytes | Major topic |
| Lymphokines | Major topic |
| Animals | |
| Cell Line | |
| Electrophoresis, Polyacrylamide Gel | |
| Guinea Pigs | |
| Immunoassay | |
| Isoelectric Focusing | |
| Isotope Labeling | |
| Lymph Nodes | |
| Macrophages | |
| Molecular Weight | |
| Receptors, Immunologic | |
| Solubility |
Source PubMed
References95
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,102,116 | Production and in vivo effect of antibodies against guinea pig lymphokines. | Cell Immunol | 1975 | https://conductscience.org/library/papers/1102116 | PubMed |
| 2 | 4,594,643 | T cell factor which can replace T cells in vivo. | Nature | 1974 | https://conductscience.org/library/papers/4594643 | PubMed |
| 3 | 6,147 | Differential transglutaminase distribution in normal rat liver and rat hepatoma. | Cancer Res | 1976 | https://conductscience.org/library/papers/6147 | PubMed |
| 4 | 1,099,092 | Enhancement of migration inhibitory factor activity by plasma esterase inhibitors. | J Biol Chem | 1975 | https://conductscience.org/library/papers/1099092 | PubMed |
| 5 | 833,546 | Macrophage plasminogen activator: induction by products of activated lymphoid cells. | J Exp Med | 1977 | https://conductscience.org/library/papers/833546 | PubMed |
| 6 | 4,808,709 | The role of properdin in the alternate pathway of complement activation. | J Exp Med | 1974 | https://conductscience.org/library/papers/4808709 | PubMed |
| 7 | 313,525 | T-cell-derived helper factor allows Lyt 123 thymocytes to differentiate into cytotoxic T lymphocytes. | Nature | 1979 | https://conductscience.org/library/papers/313525 | PubMed |
| 8 | 1,097,529 | Studies on lymphokines: the production of antibody to guinea pig lymphotoxin and its use to distinguish lymphotoxin from migration inhibitory factor and mitogenic factor. | J Immunol | 1975 | https://conductscience.org/library/papers/1097529 | PubMed |
| 9 | 4,582,841 | The production of migration inhibition factor by B and T cells of the guinea pig. | J Exp Med | 1973 | https://conductscience.org/library/papers/4582841 | PubMed |
| 10 | 341,556 | Evidence that Ia-antigens are not secreted by antigen or mitogen stimulated mouse or guinea pig lymphocytes. | Z Immunitatsforsch Immunobiol | 1978 | https://conductscience.org/library/papers/341556 | PubMed |
| 11 | 4,604,594 | Inability to block the activity of guinea pig migration inhibitory factor with di-isopropyl phosphorofluoridate. | Eur J Immunol | 1974 | https://conductscience.org/library/papers/4604594 | PubMed |
| 12 | 710,595 | Human leukocyte inhibitory factor (LIF): a lymphocyte mediator with esteratic properties. | Fed Proc | 1978 | https://conductscience.org/library/papers/710595 | PubMed |
| 13 | 1,081,576 | Properties of antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. I. In vivo activity and immunochemical characterization. | J Exp Med | 1975 | https://conductscience.org/library/papers/1081576 | PubMed |
| 14 | 55,309 | On soluble mediators of immunologic regulation. | Cell Immunol | 1976 | https://conductscience.org/library/papers/55309 | PubMed |
| 15 | 59,972 | Guinea-pig Ia antigens: functional significance and chemical characterization. | Transplant Rev | 1976 | https://conductscience.org/library/papers/59972 | PubMed |
| 16 | 5,263,842 | Relation of the migration inhibitory factor (MIF) to delayed-type hypersensitivity reactions. | Ann N Y Acad Sci | 1970 | https://conductscience.org/library/papers/5263842 | PubMed |
| 17 | 167,963 | Production of a serine-protease with macrophage migration-inhibitory factor activity by virus-transformed cells and human tumor cell lines. | Cancer Res | 1975 | https://conductscience.org/library/papers/167963 | PubMed |
| 18 | 163,038 | Collagenase production by lymphokine-activated macrophages. | Science | 1975 | https://conductscience.org/library/papers/163038 | PubMed |
| 19 | 168,779 | Production of lymphokine-like factors (cytokines) by simian virus 40-infected and simian virus 40-transformed cells. | Am J Pathol | 1975 | https://conductscience.org/library/papers/168779 | PubMed |
| 20 | 4,545,893 | Activation of T and B lymphocytes in vitro. II. Biological and biochemical properties of an allogeneic effect factor (AEF) active in triggering specific B lymphocytes. | J Exp Med | 1974 | https://conductscience.org/library/papers/4545893 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/393992
GET https://conductscience.org/api/papers/v1/393992/references?page=2